# EDGAR Filing Document

**Accession Number:** 0001355064
**File Stem:** 0001752724-25-211840
**Filing Date:** 2025-8
**Character Count:** 32308
**Document Hash:** c9b57bd2c83bbabe4e710e428825cc86
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-211840.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0001752724-25-211840

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250828

**DATE AS OF CHANGE**: 20250828

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MUTUAL FUND SERIES TRUST
- **CENTRAL INDEX KEY:** 0001355064

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21872
- **FILM NUMBER:** 251273811

**BUSINESS ADDRESS:**
- **STREET 1:** C/O GEMINI FUND SERVICES LLC
- **STREET 2:** 4221 NORTH 203RD STREET, SUITE 100
- **CITY:** ELKHORN
- **STATE:** NE
- **ZIP:** 68022-3474
- **BUSINESS PHONE:** 631 549 1859

**MAIL ADDRESS:**
- **STREET 1:** C/O GEMINI FUND SERVICES LLC
- **STREET 2:** 4221 NORTH 203RD STREET, SUITE 100
- **CITY:** ELKHORN
- **STATE:** NE
- **ZIP:** 68022-3474

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CATALYST FUNDS
- **DATE OF NAME CHANGE:** 20060303

## Series and Classes Contracts Data

### AlphaCentric Life Sciences and Healthcare Fund (Series ID: S000067055)

| Class ID   | Class Name                                             | Ticker Symbol   |
|:---|:---|:---|
| C000215729 | AlphaCentric Life Sciences and Healthcare Fund Class C | LYFCX           |
| C000215730 | AlphaCentric Life Sciences and Healthcare Fund Class I | LYFIX           |
| C000215731 | AlphaCentric Life Sciences and Healthcare Fund Class A | LYFAX           |

## Nport-Ex

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** |
| **SCHEDULE OF INVESTMENTS (Unaudited)** | **SCHEDULE OF INVESTMENTS (Unaudited)** | **SCHEDULE OF INVESTMENTS (Unaudited)** |
| **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| **Shares** |  | **Fair Value** |
|  | **COMMON STOCKS — 94.4%** |  |
|  | **BIOTECH & PHARMA - 52.2%** |  |
| 8594 | AbbVie, Inc. | &nbsp;&nbsp;&nbsp; $1595218 |
| 4206 | Agios Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 139892 |
| 4571 | Apogee Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 198519 |
| 462 | Argenx S.E. - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 254664 |
| 2194 | Ascendis Pharma A/S - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 378684 |
| 20845 | AstraZeneca plc - ADR | &nbsp;&nbsp;&nbsp; 1456649 |
| 32731 | Avadel Pharmaceuticals plc<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 289669 |
| 1280 | Axsome Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 133619 |
| 1463 | BioNTech S.E. - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 155766 |
| 10240 | Daiichi Sankyo Company Ltd. - ADR | &nbsp;&nbsp;&nbsp; 237773 |
| 6766 | Edgewise Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 88702 |
| 3657 | Eli Lilly & Company | &nbsp;&nbsp;&nbsp; 2850741 |
| 7863 | Exact Sciences Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 417840 |
| 7680 | Gilead Sciences, Inc. | &nbsp;&nbsp;&nbsp; 851482 |
| 1646 | Insmed, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 165653 |
| 5120 | Ionis Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 202291 |
| 1280 | Jazz Pharmaceuticals plc<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 135834 |
| 10971 | Johnson & Johnson | &nbsp;&nbsp;&nbsp; 1675820 |
| 1280 | Krystal Biotech, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 175949 |
| 14994 | Merck & Company, Inc. | &nbsp;&nbsp;&nbsp; 1186925 |
| 4388 | Neurocrine Biosciences, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 551528 |
| 10423 | Novartis A.G. - ADR | &nbsp;&nbsp;&nbsp; 1261287 |
| 4023 | Oruka Therapeutics, Inc. | &nbsp;&nbsp;&nbsp; 45098 |
| 25600 | Pfizer, Inc. | &nbsp;&nbsp;&nbsp; 620544 |
| 3474 | Protagonist Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 192008 |
| 366 | Regeneron Pharmaceuticals, Inc. | &nbsp;&nbsp;&nbsp; 192150 |
| 3474 | Rhythm Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 219522 |
| 2011 | Sandoz Group A.G. - ADR | &nbsp;&nbsp;&nbsp; 109931 |
| 12617 | Sanofi - ADR | &nbsp;&nbsp;&nbsp; 609527 |
| 4388 | Verona Pharma plc - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 415017 |
| 2011 | Vertex Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 895297 |
| 1646 | Zoetis, Inc. | &nbsp;&nbsp;&nbsp; 256694 |
|  |  | &nbsp;&nbsp; 17960293 |

---

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** |
| **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** |
| **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| **Shares** |  | **Fair Value** |
|  | **COMMON STOCKS — 94.4% (Continued)** |  |
|  | **HEALTH CARE FACILITIES & SERVICES - 12.7%** |  |
| 2926 | Addus HomeCare Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; $337046 |
| 731 | Cencora, Inc. | &nbsp;&nbsp;&nbsp; 219190 |
| 731 | Chemed Corporation | &nbsp;&nbsp;&nbsp; 355946 |
| 2377 | Cigna Group (The) | &nbsp;&nbsp;&nbsp; 785789 |
| 5120 | CVS Health Corporation | &nbsp;&nbsp;&nbsp; 353178 |
| 366 | Elevance Health, Inc. | &nbsp;&nbsp;&nbsp; 142359 |
| 2560 | Encompass Health Corporation | &nbsp;&nbsp;&nbsp; 313933 |
| 10606 | Surgery Partners, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 235771 |
| 4388 | UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp; 1368924 |
| 3474 | US Physical Therapy, Inc. | &nbsp;&nbsp;&nbsp; 271667 |
|  |  | &nbsp;&nbsp; 4383803 |
|  | **HEALTHCARE SERVICES - 0.7%** |  |
| 24137 | GoodRx Holdings, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 120202 |
| 33097 | Performant Healthcare, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 132388 |
|  |  | &nbsp;&nbsp; 252590 |
|  | **MEDICAL EQUIPMENT & DEVICES - 28.8%** |  |
| 6217 | Abbott Laboratories | &nbsp;&nbsp;&nbsp; 845574 |
| 32548 | Adaptive Biotechnologies Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 379184 |
| 9691 | Artivion, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 301390 |
| 17188 | AtriCure, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 563251 |
| 2560 | Becton Dickinson and Company | &nbsp;&nbsp;&nbsp; 440960 |
| 12434 | Boston Scientific Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1335537 |
| 2743 | Danaher Corporation | &nbsp;&nbsp;&nbsp; 541852 |
| 2743 | DexCom, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 239436 |
| 6217 | Edwards Lifesciences Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 486232 |
| 12068 | Globus Medical, Inc., Class A<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 712253 |
| 7314 | Hologic, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 476580 |
| 1646 | Intuitive Surgical, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 894453 |
| 2377 | iRhythm Technologies, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 365963 |
| 7497 | OrthoPediatrics Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 161036 |
| 1097 | Stryker Corporation | &nbsp;&nbsp;&nbsp; 434006 |
| 17920 | Terumo Corporation - ADR | &nbsp;&nbsp;&nbsp; 328832 |
| 2194 | Thermo Fisher Scientific, Inc. | &nbsp;&nbsp;&nbsp; 889579 |
| 731 | West Pharmaceutical Services, Inc. | &nbsp;&nbsp;&nbsp; 159943 |

---

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** | **ALPHACENTRIC LIFE SCIENCES AND HEALTHCARE FUND (LYFAX, LYFCX, LYFIX)** |
| **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** |
| **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| **Shares** |  | **Fair Value** |
|  | **COMMON STOCKS — 94.4% (Continued)** |  |
|  | **MEDICAL EQUIPMENT & DEVICES - 28.8% (Continued)** |  |
| 3840 | Zimmer Biomet Holdings, Inc. | &nbsp;&nbsp;&nbsp; $350246 |
|  |  | &nbsp;&nbsp; 9906307 |
|  | **TOTAL COMMON STOCKS (Cost $34,729,102)** | &nbsp;&nbsp; 32502993 |
|  | **SHORT-TERM INVESTMENTS — 4.2%** |  |
|  | **MONEY MARKET FUNDS - 4.2%** |  |
| 2 | Fidelity Investments Money Market Government Portfolio, Class I, 4.23%<sup>(b)</sup> | &nbsp;&nbsp;&nbsp; 2 |
| 1444389 | First American Treasury Obligations Fund, Class X, 4.24%<sup>(b)</sup> | &nbsp;&nbsp;&nbsp; 1444389 |
|  | **TOTAL MONEY MARKET FUNDS (Cost $1,444,391)** | &nbsp;&nbsp; 1444391 |
|  | **TOTAL INVESTMENTS - 98.6% (Cost $36,173,493)** | &nbsp;&nbsp;&nbsp; $33947384 |
|  | **OTHER ASSETS IN EXCESS OF LIABILITIES - 1.4%** | &nbsp;&nbsp; 471860 |
|  | **NET ASSETS - 100.0%** | &nbsp;&nbsp; $34419244 |

---

---

| | |
|:---|:---|
| ADR | - American Depositary Receipt |
| A/S | - Anonim Sirketi |
| LTD | - Limited Company |
| PLC | - Public Limited Company |
| <sup>(a)</sup> | Non-income producing security. |
| <sup>(b)</sup> | Rate disclosed is the seven day effective yield as of June 30, 2025. |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** MUTUAL FUND SERIES TRUST

- **b. Investment Company Act file number:** 811-21872

- **c. CIK number of Registrant:** 0001355064

- **d. LEI of Registrant:** 5493002ZGLQMLR4QMA96

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** C/O GEMINI FUND SERVICES LLC

  - **City:** ELKHORN

  - **State:** NE

  - **Foreign country:** US

  - **Zip / Postal Code:** 68022

  - **Telephone number:** 631-470-2600

**Item A.2. Information about the Series.**

- **a. Name of Series:** AlphaCentric Life Sciences and Healthcare Fund

- **b. EDGAR series identifier (if any):** S000067055

- **c. LEI of Series:** 549300XV4TMPQ6UX8179

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $34493358.16

**Total Liabilities:** $74114.21

**Net Assets:** $34419243.95

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000215729 | -3.56%               | -4.18%               | 1.88%                |
| Class ID C000215731 | -3.49%               | -4.18%               | 2.01%                |
| Class ID C000215730 | -3.38%               | -4.22%               | 2.08%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-943773.10              | $-601700.13                                |
| Month 2  | $-713861.56              | $-1013872.95                               |
| Month 3  | $-311046.56              | $1040151.82                                |

### Schedule of Portfolio Investments

| Name                                      | Title                     | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Atricure Inc                              | ATRICURE INC              | CUSIP: 04963C209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17188 | NS      | $563250.76    | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| DexCom Inc                                | DEXCOM                    | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |      2743 | NS      | $239436.47    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| US Physical Therapy Inc                   | US PHYSICAL THER          | CUSIP: 90337L108<br>LEI: 529900KL1UXQYFIOMY96 | Long             | EC               | CORP              | US        |      3474 | NS      | $271666.80    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Irhythm Technologies Inc                  | IRHYTHM TECHNOLO          | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |      2377 | NS      | $365962.92    | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                                 | SANOFI-ADR                | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     12617 | NS      | $609527.27    | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp             | ADAPTIVE BIOTECH          | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |     32548 | NS      | $379184.20    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Verona Pharma Plc                         | VERONA PHAR-ADR           | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |      4388 | NS      | $415017.04    | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| The Cigna Group                           | THE CIGNA GROUP           | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |      2377 | NS      | $785788.66    | 2.28%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                           | ASTRAZENECA-ADR           | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     20845 | NS      | $1456648.60   | 4.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Incorporated       | VERTEX PHARM              | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      2011 | NS      | $895297.20    | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corporation                       | STRYKER CORP              | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |      1097 | NS      | $434006.11    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc.                      | ELEVANCE HEALTH           | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |       366 | NS      | $142359.36    | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc.                  | AXSOME THERAPEUT          | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |      1280 | NS      | $133619.20    | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC                | AVADEL PHARMACEU          | CUSIP: G29687103<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |     32731 | NS      | $289669.35    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Chemed Corporation                        | CHEMED CORP               | CUSIP: 16359R103<br>LEI: 54930020031IDJT2IM79 | Long             | EC               | CORP              | US        |       731 | NS      | $355945.83    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corporation             | BOSTON SCIENTIFC          | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |     12434 | NS      | $1335535.94   | 3.88%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Funds Inc.                 | FIRST AM-TR OB-X          | CUSIP: 31846V328<br>LEI: 549300J5J5SJCZ9IA369 | Long             | STIV             | RF                | US        |   1444390 | PA      | $1444389.84   | 4.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corporation                       | DANAHER CORP              | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      2743 | NS      | $541852.22    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Med Inc                            | GLOBUS MEDICAL I          | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     12068 | NS      | $712253.36    | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                               | BIONTECH SE-ADR           | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |      1463 | NS      | $155765.61    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton, Dickinson and Company             | BECTON DICKINSON          | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |      2560 | NS      | $440960.00    | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                | RHYTHM PHARMACEU          | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |      3474 | NS      | $219522.06    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Terumo Corp.                              | TERUMO CORP-ADR           | CUSIP: 88156J105<br>LEI: 353800JX1R4582QVK932 | Long             | EC               | CORP              | JP        |     17920 | NS      | $328832.00    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc.                      | GILEAD SCIENCES           | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      7680 | NS      | $851481.60    | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc.                  | APOGEE THERAPEUT          | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4571 | NS      | $198518.53    | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                | ZIMMER BIOMET HO          | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |      3840 | NS      | $350246.40    | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.           | REGENERON PHARM           | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       366 | NS      | $192150.00    | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                 | ARGENX SE - ADR           | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       462 | NS      | $254663.64    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc.                   | UNITEDHEALTH GRP          | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |      4388 | NS      | $1368924.36   | 3.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corporation                | EXACT SCIENCES            | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |      7863 | NS      | $417839.82    | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc.                               | ABBVIE INC                | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      8594 | NS      | $1595218.28   | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Orthopediatrics Corp.                     | ORTHOPEDIATRICS           | CUSIP: 68752L100<br>LEI: 5493000KUTPFGOPAT717 | Long             | EC               | CORP              | US        |      7497 | NS      | $161035.56    | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals Inc                 | AGIOS PHARMACEUT          | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |      4206 | NS      | $139891.56    | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                       | ASCENDIS PHA-ADR          | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |      2194 | NS      | $378684.40    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                         | JOHNSON&JOHNSON           | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     10971 | NS      | $1675820.25   | 4.87%             |  |  |  | No            |                  1 | On Loan: No      |
| GoodRx Holdings Inc                       | GOODRX HOLDIN-A           | CUSIP: 38246G108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24137 | NS      | $120202.26    | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc              | PROTAGONIST THER          | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3474 | NS      | $192007.98    | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                           | ELI LILLY & CO            | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      3657 | NS      | $2850741.21   | 8.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                | NEUROCRINE BIOSC          | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      4388 | NS      | $551527.72    | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Artivion Inc                              | ARTIVION INC              | CUSIP: 228903100<br>LEI: 549300YTKV8DMSMG6K81 | Long             | EC               | CORP              | US        |      9691 | NS      | $301390.10    | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc.                               | ZOETIS INC                | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |      1646 | NS      | $256693.70    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                           | CVS HEALTH CORP           | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |      5120 | NS      | $353177.60    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Sandoz Group AG                           | SANDOZ GROU-ADR           | CUSIP: 799926100<br>LEI: 5493000JWK6XWFEUD320 | Long             | EC               | CORP              | CH        |      2011 | NS      | $109931.32    | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Incorporated | WEST PHARMACEUT           | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |       731 | NS      | $159942.80    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc.                               | PFIZER INC                | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |     25600 | NS      | $620544.00    | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Oruka Therapeutics Inc                    | ORUKA THERAPEUTI          | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |      4023 | NS      | $45097.83     | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corporation          | EDWARDS LIFE              | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |      6217 | NS      | $486231.57    | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                               | HOLOGIC INC               | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |      7314 | NS      | $476580.24    | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Addus Homecare Corp                       | ADDUS HOMECARE            | CUSIP: 006739106<br>LEI: 52990090ZT33AKPDBX62 | Long             | EC               | CORP              | US        |      2926 | NS      | $337045.94    | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Colchester Street Trust          | FID-MM GOVT-I             | CUSIP: 316175108<br>LEI: 549300SHPEJB1OPRCV46 | Long             | STIV             | RF                | US        |         2 | PA      | $1.54         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                               | CENCORA INC               | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |       731 | NS      | $219190.35    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                | INSMED INC                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      1646 | NS      | $165653.44    | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co., Inc                          | MERCK & CO                | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     14994 | NS      | $1186925.04   | 3.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc.                | EDGEWISE THERAPE          | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6766 | NS      | $88702.26     | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corporation              | ENCOMPASS HEALTH          | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |      2560 | NS      | $313932.80    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                       | ABBOTT LABS               | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |      6217 | NS      | $845574.17    | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Daiichi Sankyo Co Ltd.                    | DAIICHI SAN-ADR           | CUSIP: 23381D102<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |     10240 | NS      | $237772.80    | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc.                   | INTUITIVE SURGIC          | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |      1646 | NS      | $894452.86    | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                  | JAZZ PHARMACEUTI          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |      1280 | NS      | $135833.60    | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.               | IONIS PHARMACEUT          | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      5120 | NS      | $202291.20    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc              | THERMO FISHER             | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |      2194 | NS      | $889579.24    | 2.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                       | KRYSTAL BIOTECH           | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      1280 | NS      | $175948.80    | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Performant Healthcare Inc.                | PERFORMANT FINANCIAL CORP | CUSIP: 71377E105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     33097 | NS      | $132388.00    | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                               | NOVARTIS AG-ADR           | CUSIP: 66987V109<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     10423 | NS      | $1261287.23   | 3.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Surgery Partners Inc                      | SURGERY PARTNERS          | CUSIP: 86881A100<br>LEI: 549300LC82HG33S19I03 | Long             | EC               | CORP              | US        |     10606 | NS      | $235771.38    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-28

**Name of Applicant:** MUTUAL FUND SERIES TRUST

**Signature:** Erik Naviloff

**Name of Signer:** Erik Naviloff

**Title:** Treasurer